Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-02

Clinical Trial Update: Vildagliptin Versus Dapagliflozin on Glucagon [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing vildagliptin versus dapagliflozin assessing effects on glucagon in type 2 diabetes completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)
  • Vildagliptin (vildagliptin)

Snippet

Sponsor: Lund University | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2019-05-02